HPV vaccine pilot shows promise for High-Risk groups
Prevention
Completed
This completed pilot study enrolled 101 transgender women and men who have sex with men to see how acceptable the HPV vaccine (Gardasil 9) is in these groups. Participants received three doses over six months, and researchers tracked how many completed the series and how common a…
Phase: PHASE4 • Sponsor: Fundación Huésped • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC